Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover and develop drugs globally. The company is headquartered in San Diego, California.
52W High
$169.49
52W Low
$93.58
MA Status:
50D: Above
200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.84
Valuation
Fair
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
22.42
EV/EBITDA (<8 favorable)
19.13
EV/Revenue (<3 favorable)
16.00
P/S (TTM) (<3 favorable)
17.33
P/B (<3 favorable)
3.92
Ownership
Institution‑heavySource: Overview
Insiders (1–5% typical)
2.30%
Institutions (25–75% balanced)
100.29%
Shares Outstanding
19,494,500
Float
19,164,300
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
2010-07-02
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
187,584,000
Gross Profit (TTM)
107,790,000
EPS (TTM)
-4.04
Profit Margin (>10% good)
-0.40%
Operating Margin (TTM) (higher better)
0.20%
ROE (TTM) (>15% strong)
-0.09%
EPS YoY (Quarterly) (>10% good)
1.03
Revenue YoY (Quarterly) (>8% good)
0.15
Momentum
Bearish momentumValue
7.0558
Previous
7.4767
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025